CAS: 252343-27-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Efavirenz Impurity 21 REF: 4Z-E-0740CAS: | - - - | To inquire | Mon 30 Sep 24 |
 | (S)-8,14-Dihydroxy Efavirenz REF: TR-D468240CAS: 252343-27-4 | - - - | 1,336.00 €~9,690.00 € | Tue 01 Oct 24 |
 | (S)-8,14-Dihydroxy efavirenz REF: 3D-CKA34327CAS: 252343-27-4 | Min. 95% | To inquire | Mon 04 Nov 24 |
Ref: 4Z-E-0740
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 30 Sep 2024
(S)-8,14-Dihydroxy Efavirenz
Controlled ProductCAS:252343-27-4
Applications (S)-8,14-Dihydroxy Efavirenz, is a metabolite of Efavirenz (E425000), a nonnucleoside HIV-1 reverse transcriptase inhibitor. …
Formula:
C14H9ClF3NO4
Color and Shape:
Neat
Molecular weight:
347.67
Ref: TR-D468240
| 1mg | 1,336.00 € | ||
| 5mg | 5,090.00 € | ||
| 10mg | 9,690.00 € |
Estimated delivery in United States, on Tuesday 1 Oct 2024
(S)-8,14-Dihydroxy efavirenz
CAS:252343-27-4
(S)-8,14-Dihydroxy efavirenz is a medicinal analog that has shown potential anticancer activity. It is a …
Formula:
C14H9ClF3NO4
Purity:
Min. 95%
Molecular weight:
347.67 g/mol
Ref: 3D-CKA34327
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 4 Nov 2024
